The FDA has cleared Micro Dose by EOS imaging, a low dose option now available on EOS equipment.
EOS imaging received U.S. FDA clearance for Micro Dose, an option now available on EOS equipment that lowers dose of pediatric spine follow-up imaging exams, the company announced.
Micro Dose is designed for pediatric patients with orthopedic conditions that require frequent imaging exams for continuous monitoring of disease progression and treatment, the company said. Initial results presented at RSNA 1014 showed that Micro Dose generates dosage levels equivalent to a week of naturally-occurring background radiation in pediatric patients receiving 2D and 3D follow-up examinations, the company announced.
Micro Dose is in full accordance with the As Low As Reasonably Achievable (ALARA) principle, Marie Meynadier, CEO of EOS imaging, said in a release.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.